89Bio shareholder RA Capital bought 275,000 shares, while Aprea beneficial owner KDev sold 241,703 shares. Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant Insider purchases reported in the prior week from July 6 through July 10 include:
- Shareholder of 89Bio (ETNB) RA Capital purchased 275,000 shares of stock at $27.50 per share for a total transaction value of $7,562,500
- Chairman of Vaccinex (VCNX) Albert Friedberg purchased 1,126,760 shares of stock at $3.55 per share for a total transaction value of $3,999,998
- Chairman of W&T Offshore (WTI) Tracy Krohn purchased 346,358 shares of stock at $2.15 per share for a total transaction value of $744,670
- CEO of Cooper Companies (COO) Albert White purchased 1,000 shares of stock at $278.23 per share for a total transaction value of $278,230
- Director of Syneos Health (SYNH) John Dineen purchased 8,691 shares of stock at $59.11 per share for a total transaction value of $513,725
NOTABLE INSIDER SALES: Significant Insider sales reported in the prior week from July 6 through July 10 include:
- President of Adaptive Biotechnologies (ADPT) Julie Rubinstein sold 15,275 shares of stock at $49.00 per share for a total transaction value of $748,475
- COO of Alnylam Pharmaceuticals (ALNY) Yvonne Greenstreet sold 1,236 shares of stock at $161.00 per share for a total transaction value of $1,808,996
- Officer of Bill.Com (BILL) Rajesh Aji sold 14,000 shares of stock at $87.61 per share for a total transaction value of $1,226,596
- Director of Ciena (CIEN) Bruce Claflin sold 18,600 shares of stock at $56.22 per share for a total transaction value of $1,045,735
- Beneficial owner of Aprea Therapeutics (APRE) KDev sold 241,703 shares of stock at $34.55 per share for a total transaction value of $8,350,839.
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Shares of 89Bio are up 25% after RA Capital purchased shares, while shares of Aprea are down 17%.
Symbols:
ETNB VCNX WTI COO SYNH ADPT ALNY BILL CIEN APRE Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC